FDA Approved: TRAZIMERA — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved TRAZIMERA (trastuzumab-qyyP) from Pfizer as an original biologics license application. It is a biosimilar to trastuzumab indicated for HER2-positiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Adenocarcinoma

Drugs mentioned

• TRAZIMERA (TRASTUZUMAB-QYYP)

Snippet

ORIG AP for TRAZIMERA (TRASTUZUMAB-QYYP)